Purification, characterization, and expression of CFTR nucleotide-binding domains

Area of Science:

• Molecular Biology
• Biochemistry
• Cell Biology

Background:

• The cystic fibrosis transmembrane conductance regulator (CFTR) protein is crucial for anion transport.
• Its nucleotide binding domains (NBDs) were initially thought to be cytoplasmic and gate a membrane pore.
• Understanding NBD function is key to deciphering CFTR mechanisms.

Purpose of the Study:

• To characterize the isolated first nucleotide binding domain (NBD-1) of CFTR.
• To investigate its biophysical properties and cellular localization.
• To explore the impact of mutations on NBD-1 function and CFTR-related diseases.

Main Methods:

• Biochemical assays to assess nucleotide binding affinity.
• Spectroscopic methods to determine secondary structure (beta sheet content).
• Liposome disruption assays and planar lipid bilayer experiments.
• Expression of NBD-1 in human epithelial cells, including CF patient cells.

Main Results:

• NBD-1 binds nucleotides with affinity comparable to full-length CFTR.
• NBD-1 exhibits high beta sheet content in solution and forms large polymers.
• The domain is highly lipophilic, disrupts liposomes, and integrates into lipid bilayers.
• NBD-1 alone targets the plasma membrane and mediates anion permeability in epithelial cells.

Conclusions:

• NBD-1 possesses intrinsic properties enabling membrane interaction and anion transport.
• Clinically relevant mutations may impair NBD-1 nucleotide binding or folding.
• NBD-1's independent function provides a novel perspective on CFTR structure-function relationships.